Malaysia takes the lead on a public health approach to hepatitis C with new initiative to enhance diagnosis & treatment

New agreement between Clinical Research Malaysia & FIND on R&D for hepatitis C diagnostic tests continues an existing Malaysian partnership with DNDi for hepatitis C treatment

The Foundation for Innovative New Diagnostics (FIND) and Clinical Research Malaysia (CRM), both DNDi partners, recently signed a memorandum of understanding (MoU) to collaborate in the research and development of an innovative hepatitis C diagnostic testing strategy.

FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment

Amsterdam/Geneva – 23 July 2018
Initiative in Malaysia to enhance country’s public health approach to hepatitis C
FIND and the DNDi will partner to generate evidence that will support policy change and scale up of hepatitis C diagnosis and treatment. This work, announced at the AIDS 2018 conference in Amsterdam and ahead of World Hepatitis Day 2018, is being conducted in collaboration with the Ministry of Health in Malaysia with a view to overcoming barriers to diagnosis and treatment.

Seminar on Evidence in Action

1 October 2018 
Subang Jaya, Malaysia
Jean-Michel Piedagnel, Head of DNDi South East Asia – presentation on affordable treatment for hepatitis C

Matichon Online: “คร.ร่วมหลายหน่วยงานชูความสำเร็จโครงการวิจัยยารักษาผู้ป่วยไวรัสตับอักเสบซี”

Matichon Online [7 May 2018] “คร.ร่วมหลายหน่วยงานชูความสำเร็จโครงการวิจัยยารักษาผู้ป่วยไวรัสตับอักเสบซี” – “Many organizations join in the success of the drug research program to treat patients with hepatitis C” Click here to read the article

MGR Online: “วิจัยพบยาคู่ใหม่ “โซฟอสบูเวียร์+เรวิดาสเวียร์” รักษา “ตับอักเสบซี” หายขาด 96-100%”

MGR Online [7 May 2018] “วิจัยพบยาคู่ใหม่ ‘โซฟอสบูเวียร์+เรวิดาสเวียร์’ รักษา ‘ตับอักเสบซี’ หายขาด 96-100%” – “New drug discovery ‘sofosbuvir + ravidasvir’ treatment ‘hepatitis C’ cured 96-100%” Click here to read the article